chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Continual 24/7 head pain; neuralgia in occipital and trigeminal areas of the head.; neuralgia in occipital and trigeminal areas of the head.  Debilitating.; Debilitating.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Apr2021 11:45 (Lot number: EW0164) at the age of 59 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Diabetes" (unspecified if ongoing); "Pulmonary Embolisms" (unspecified if ongoing); "pneumonia" (unspecified if ongoing); "Known allergies: Mushrooms" (unspecified if ongoing), notes: Known allergies: Mushrooms, aloe, iodine MRI solution; "Known allergies: aloe" (unspecified if ongoing), notes: Known allergies: Mushrooms, aloe, iodine MRI solution; "Known allergies: iodine MRI solution" (unspecified if ongoing), notes: Known allergies: Mushrooms, aloe, iodine MRI solution. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EP7543, Location of injection: Arm Left, Vaccine Administration Time: 04:45 PM), administration date: 28Mar2021, for COVID-19 immunization. No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. The following information was reported: HEADACHE (disability), outcome "not recovered", described as "Continual 24/7 head pain"; OCCIPITAL NEURALGIA (disability), outcome "not recovered", described as "neuralgia in occipital and trigeminal areas of the head."; TRIGEMINAL NEURALGIA (disability), outcome "not recovered", described as "neuralgia in occipital and trigeminal areas of the head. Debilitating."; ASTHENIA (disability), outcome "not recovered", described as "Debilitating.". The events "continual 24/7 head pain", "neuralgia in occipital and trigeminal areas of the head." and "neuralgia in occipital and trigeminal areas of the head. debilitating." were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (04Jun2021) negative, notes: nasal Swab. Therapeutic measures were taken as a result of headache, occipital neuralgia, trigeminal neuralgia, asthenia.  No follow-up attempts are possible. No further information is expected.
Child had seizure (lost consciousness and stopped breathing) 1 week after 1st dose of Pfizer COVID-19 vaccine.  Child was transported via ambulance to Hospital where she was admitted and will be spending the night.  Cause of seizure unknown at this time, no previous history of seizures.
pain at injection site, pain on right side of the throat with swallowing and right cervical lymphadenopathy.
goose-egg red, warm, itchy area on rt upper arm began the same evening;gradual improvement p/3 days;
1/29/21 had mild arm pain and low grade temperature for 24 hours. Headache for multiple days after vaccine. 2/13/2021 noticed rash, like heat rash, on legs bilaterally.  Put on hydrocortosone cream and then area burned and got very painful. Employee took zyertec for itching. Swelling noted in both lower legs and feet.  Lower legs and feet showed petechaie and purpura from knees to toes.  On 2/15/2021 saw MD and prescribed steroid.  Petechaie improving but area is still red/purple and itchy.  Will follow up with a dermatologist.
Brain fog for several days. Multiple  Papules along right arm and left forearm. Open weeping blisters on right  arm. Open weeping blisters on left middle finger.  Approximately seven days after the first injection. The area continued to show signs of infection. Cellulitis around forearm. Temperatures reaching 100°  During the evening hours.   Rash on neck and face approximately seven days after the second injection on 6/8/2021.   Went to Dr on 6/15/2021 and was given RX prednisone 40 mg QD x 5 days and Doxycycline 100mg BID x7 days
Dizziness; Cold sweat; Fatigue and feeling exhausted; But has some sweatiness; "face was damp-ish".; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (Cold sweat), HYPERHIDROSIS (But has some sweatiness; "face was damp-ish".), DIZZINESS (Dizziness) and FATIGUE (Fatigue and feeling exhausted) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced FATIGUE (Fatigue and feeling exhausted). On 14-Nov-2021, the patient experienced COLD SWEAT (Cold sweat). On 14-Nov-2021 at 3:00 PM, the patient experienced DIZZINESS (Dizziness). In November 2021, the patient experienced HYPERHIDROSIS (But has some sweatiness; "face was damp-ish".). On 13-Nov-2021, FATIGUE (Fatigue and feeling exhausted) had resolved. On 14-Nov-2021 at 4:00 PM, DIZZINESS (Dizziness) had resolved. At the time of the report, COLD SWEAT (Cold sweat) and HYPERHIDROSIS (But has some sweatiness; "face was damp-ish".) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
Breakthrough case of COVID-19 on 06/01/2022 after returning from a bus trip. I had mild symptoms like a head cold, body aches, headache. I did request Paxlovid and on the 5th to 6th day of being positive I tested negative. I have not been having any lingering symptoms since then. I did not have a fever during any of this.
Patient was given a second vaccine dose of Hepatitis A approximately 44 days after first dose was given. The recommended interval between 1st and 2nd doses is 6 months. This was noted until 4/20/22 when patient called the Employee Health office to schedule a visit to receive the 2nd Hepatitis A vaccine.
This spontaneous report as received from a pharmacist refers to unspecified number of patients. The pharmacist reported that she had some patients with certain condition, like COPD, who received PNEUMOVAX23 (lot number, dose, route and injection site were not reported) every year. No other co-suspects were reported. No concomitant medications were reported. Specific number of patients unknown. This is one of several reports received from the same source. Additional information has been requested.
Severe eye swelling underneath and lids, migraines and fever of 103 degrees within 18 hours of injection. Symptoms lasted for 2-3 days.
There was no adverse event but facility would like to report that this patient received the Johnson & Johnson vaccine from another facility on 3/18/21 and then came to our location on 6/24/21 requesting to be vaccinated.  We have moderna and she received a single dose on that date. she returned on 8/12/21 asking for her 2nd moderna vaccination and the issue was discovered so she was denied.
Rash on both arms on antecubital fossa as well as on both legs in popliteus area. Rashes come and go and are in the shape of red rings. There is no itching or pain but they do get warm to touch. After 3rd booster shot, rings also appear on armpits
Brain fog, eye floaters and ringing in the ears. Brain fog lasted about a month and a half, eye floaters and tinnitus still an ongoing nuisance. I saw my ENT on May 3 but he didn't see anything wrong with my ears.
Narrative:  Pt was a 72 YO M with PMH of DM2, lung cancer, CHF, COPD, hypothyroidism, stroke, CAD, HLD, HTN, and BPH who was admitted to hospital for cardiac arrest. Pt was admitted to the ICU at hospital with aggressive resuscitative measures. Family made the decision to make patient DNR and he subsequently passed. No evidence that death was related to COVID-19 vaccine.
arms pain, back pain, spine pain 4 hours only. pain dropped to lower back and hips and lasted for a few hours. Recurring pain since.
My legs and feet are tingling, my hands are tingling, face is tingling, my lips are tingling; I ended up with a surface blood cloth in my leg; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOPHLEBITIS SUPERFICIAL (I ended up with a surface blood cloth in my leg) and PARAESTHESIA (My legs and feet are tingling, my hands are tingling, face is tingling, my lips are tingling) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 046A21A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer and Autoimmune disorder.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Jul-2021, the patient experienced THROMBOPHLEBITIS SUPERFICIAL (I ended up with a surface blood cloth in my leg). In August 2021, the patient experienced PARAESTHESIA (My legs and feet are tingling, my hands are tingling, face is tingling, my lips are tingling). At the time of the report, THROMBOPHLEBITIS SUPERFICIAL (I ended up with a surface blood cloth in my leg) had resolved and PARAESTHESIA (My legs and feet are tingling, my hands are tingling, face is tingling, my lips are tingling) had not resolved.            It was reported that patient takes steroids as concomitant medication Treatment information was not reported by reporter
Nausea  Vomiting low grade fever 100.0 body aches  restlessness   all lasting 24 hours after the following day went back to normal
Pt reported on 9/5/18 extreme pain in arm ever since inj given, as well as large bump under skin where inj was given. No rash or redness/discoloration in area. Pt informed to treat for now w/heat compressors per provider.
This case was reported by a healthcare professional and described the occurrence of swelling of legs in a 4-year-old male subject who was vaccinated with INFANRIX (GlaxoSmithKline). Previous and/or concurrent vaccination included diphtheria and tetanus toxoids and acellular pertussis vaccine; GlaxoSmithKline; intramuscular given on an unspecified date: inactivated poliomyelitis virus vaccine; Aventis Pasteur; unknown given on 4 August 2007; live attenuated MMR II; Merck; unknown given on 4 August 2007; MMR, strain not specified; Merck; unknown given on 4 August 2007. On 4 August 2007 the subject received 5th dose of INFANRIX (.5 ml, intramuscular, left thigh). On 6 August 2007, 2 days after vaccination with INFANRIX, the subject experienced swelling of legs, nodule at injection site, redness, painful to walk and pharmaceutical product complaint. The subject was seen in the emergency department and had a Magnetic resonance imaging performed that "was fine". The reporter strongly felt there was a quality issue with INFANRIX. The healthcare professional considered the events were disabling. In October 2007, the events were resolved. The healthcare professional considered the events were probably related to vaccination with INFANRIX.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 14-NOV-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 0.5 mL (Vls 10 SDV) (Lot # K007822, expiration date 15-AUG-2015) dose, route and anatomical location were not provided. There was no concomitant medication provided. On an unknown date, the PNEUMOVAX had a temperature excursion for 1704 hours, the highest recorded temperature was 59.9 F (15.5 Celsius). The vaccine status was reported as "in excursion", and was storage in a Refrigerator (R). There was no product quality complaint involved and no adverse effects were reported. This is one of several cases received from the same reporter. Additional information has been requested.
Information has been received from a Physician assistant concerning a female patient who on an unspecified date was vaccinated with a dose of GARDASIL (lot # not reported). The patient experienced hair loss after receiving GARDASIL. At the time of the report, the patient's outcome was unknown. It was unknown if the patient sought medical attention. Additional information has been requested.
Patient contacted pharmacy stating she had swelling in right arm from injection site to wrist.  Patient was admitted to emergency room (ER).  ER physician diagnosed her with bacterial infection. Patient was prescribed norco 10, bactrim ds, and Benadryl 25 mg.
Our son has been having severe bowel cramping ever since the first dose of the rotavirus vaccine RotaTeq.  He has suffered from abdominal cramping, severe crying spells, problems passing bowel movements, decreased appetite, fussiness, and loss of sleep.  After having the second dose of the vaccine, his symptoms worsened until he finally developed intussuception.  The day he developed this adverse reaction he began the morning with his usual fussiness.  He hadn't slept well the night before and was having trouble being held and bending in the middle.  As I tried to give him his morning feeding, he persistantly refused to nurse and became more and more fussy.  He arched his back and his stomach became hard.  He began screaming out in pain and essentially foaming at the mouth. Following a severe screaming and crying spell, he went into shock.  His skin became cool and clammy and he went limp in my arms. We called the pediatrician and they told us to take a rectal temperature.  While taking a rectal tempature he passed a large bowel movement containing jelly-like blood clots.  We rushed him to the emeregency room where he began to wheeze and vomit up bile.  They took an X-ray of his abdomin, and followed up the X-ray with an ultrasound.  The ultrasound confirmed the bowel telescoping.  They did an air contrast enema to reduce the obstruction and then kept him in the hospital for the next two days for monitoring.  When we met with our pediatrician following the intussuception, he didn't mention that it could be related to the rotavirus vaccine.  He went ahead and administered the third dose of the vaccine about a month after our son's hospitalization.  Since the third dose of the vaccine, we have been back to the emergency room with the same symptoms, but the bowel twisting has resolved itself without further medical enemas.   3/23/07 Received ER medical records which reveal patient experienced nasal congestion, pulling at left ear & irritability for approx 3 days prior to being seen in ER on 3/18/07.  Exam revealed reddened left TM. PMH: s/p IS 3 wks ago. FINAL DX: left otitis media. 4/13/07 Received medical records from treating hospital which reveals patient experienced jaw clenching, diaphoresis, screaming, pallor, gen fussiness & bloody stools.  In ER had bilious vomiting.  Held overnight s/p IS reduction by enema.  Progressed well & d/c to home. FINAL DX: Intussusception, reduced by air contrast enema.
Hide copied text  Hover for details FINAL IMPRESSION 1. Adverse effect of COVID-19 vaccine  2. Hypokalemia  3. Acute alcoholic gastritis without hemorrhage      PLAN New Prescriptions   FAMOTIDINE (PEPCID) 20 MG TABLET    Take 1 tablet by mouth 2 times daily.   ONDANSETRON (ZOFRAN) 8 MG TABLET    Take 1 tablet by mouth every 8 hours as needed for Nausea.   Discharge Instructions    I do suspect that part of your feeling poorly is from the Covid vaccine.  However you are difficult situation also makes you quite vulnerable to feeling fatigued and worn out.  The alcohol I am afraid is really bothering your stomach.  Please cut down the wine as much as possible.  I am afraid you are starting to irritate the lining of your stomach.  I put you on an acid blocking medication given you something for nausea.
Shortness of breath; Tight chest; chest muscle pain.; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 30Apr2021 at 08:45(at the age of 35-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included unspecified prenatals from an unknown date for an unknown indication and unknown if ongoing. On 07May2021 at 08:00, the patient experienced shortness of breath, tight chest and chest muscle pain. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shortness of breath, tight chest and chest muscle pain were not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
received Shingrix second dose 2 weeks after the first dose instead of 2 months; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number F4LD5, expiry date 27-SEP-2025) for prophylaxis.   Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX).   On 26-OCT-2023, the patient received the 2nd dose of Shingrix. On 26-OCT-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: received Shingrix second dose 2 weeks after the first dose instead of 2 months). The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK receipt date: 26-Oct-2023 The reporter did not consent to follow-up. The patient received second dose of Shingrix earlier than the recommended interval, which led to shortening of vaccine schedule.
This spontaneous report as received from a physician refers to a 74 years old female patient who with none drug reactions/allergies and none pertinent medical history. On 14-SEP-2012 the patient was vaccinated with ZOSTAVAX (one time injection) for shingles prevention. Concomitant medications included: antiviral (unspecified). On 20-SEP-2012 the patient experienced mild case of shingles, itching on her chin, up her left cheek and to her left ear, sensitivity on the back of her head. The patient had sought medical attention. Unspecific treatment was given to the patient. The lab diagnostics was not performed. Additional information has been requested.
A physician reported that a 70 year old female received Pnu-Imune 23 and Fluzone vaccines on 11/13/00. A "few" minutes, post vax, the pt developed arthritis type symptoms described as arthralgia and myalgia of both arms and effusion of her right shoulder. On 11/17/00, she was seen by the physician who "tapped" her shoulder and treated her with ibuprofen and Tylenol. The reporter stated that blood work showed an elevated ANA and "some of her CBC was abnormal". The reporter also indicated that this was a new pt and blood levels "could have been elevated prior to vaccination". This is 1 of 2 pts from this facility who had an adverse experience following receipt of Pnu-Imune 23 (lot 466786).
Per patient: On Friday evening, my left arm (where I got the tetanus/pertussis shot) started aching.  I woke up in the middle of the night in extreme pain, unable to move that arm, feeling very nauseous and dizzy.  My arm was very swollen, hot, hard and red.  I felt awful on Saturday and paged your doctor on call, who advised me to go to the ER.  I had made it up to my parents house and planned on going to the ER there, but I took my temperature and it was normal, and I just felt like I wanted to sleep, so I took some Advil and slept for 14 hours at their house.  Sunday I still felt awful, no change in my arm, but I drove home.  Monday I continued to have flu-like symptoms -- dizzy, nauseous, achy, and my arm remained swollen, tender, hot and red.  I did not go to work, and insisted on taking me to the ER.  My temp was still normal, but my BP was very low (90/66), and the PA I saw thought I had a systemic infection going on from the vaccine, and put me on antibiotics.  I missed work again on Tuesday. I started feeling a little better on Weds. and went back to work.  My arm has started to feel better, but I still have flu-like symptoms.  Today I have taken 9 Advil since this morning and still have a splitting head and neck-ache and my arm is aching.  I am having a hard time getting comfortable enough to sleep feeling this achy and am not sleeping well.  I feel really run down and exhausted.  I don't think I simply caught the flu because of the onset of the symptoms in conjunction with the vaccine, and also b/c I am not vomiting or congested... just in pain and exhausted.  I am also still quite dizzy.  I am toughing out work b/c I have a lot going on right now and couldn't stay out any longer, but am feeling just lousy.
swollen(joint); red (joint); This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (swollen(joint)) and ERYTHEMA (red (joint)) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced JOINT SWELLING (swollen(joint)) and ERYTHEMA (red (joint)). At the time of the report, JOINT SWELLING (swollen(joint)) and ERYTHEMA (red (joint)) outcome was unknown.
Swelling / soreness in arm  Severe headache, nausea, vomiting, loose bowels,  Fever ,  body aches.  Began at 4 am 12-30-2020
Eyes were swollen shut on 7/12, lips swollen, severe nasal congestion, errythema, mass at injection site, fever 103F on 7/13 early morning.  Patient took Benadryl PO at home, then went to the ED in Opelousas where they gave her Benadryl IM, Tylenol and an ice pack for her arm.
Information has been received from a consumer concerning her 73 year old husband with an "unremarkable" medical history and no known allergies, who in January 2008, was vaccinated with ZOSTAVAX (Oka/Merck).  Concomitant therapy included clopidogrel bisulfate (PLAVIX) and simvastatin (MSD).  Subsequently, two weeks after receiving the vaccine the patient was diagnosed with a disease called "transverse myolitis" and was hospitalized for about 4 weeks.  The patient had CT Scans, MRI, Lumbar Puncture, Blood Tests, and a Bone Marrow Biopsy, the results were not reported.  At the time of the report the patient has not recovered.  He has been hospitalized for the past 4 weeks.  Additional information has been requested. 8/25/08-records received for DOS 2/27-3/14/08-DC DX: Transverse myelitis. Anemia. Positive ANA. Hyperlipidemia. Presented to ED with gait disturbance and inability to walk. Difficulty walking for 2-3 days. Felt weak and tired.
Post vax,a the pt became faint. She then experienced unconciousness and had a seizure. Treated with epinephrine. She again experienced faintness and seizures. It was recommended she be transported to ER, but pt refused. She left the health department in stable condition.
Moderna COVID-19 Vaccine EUA Side effects:  Injection site soreness Stiff neck Headache Fatigue
There was a tumor growth on my salivary gland which had to be surgically removed and was non cancerous